Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

Cognitively engaging walking exercise and brain stimulation for older adults

Official title: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults

Run by University of Florida · NCT05830942 · Data updated 2026-11-12

This study is testing if combining brain stimulation with fun walking exercises can help older adults with mild to moderate cognitive decline improve their thinking and walking skills.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment120 (estimated)
SponsorUniversity of Florida
Academic / other
Locations2 sites (Gainesville, Florida and 1 other locations)
StatusRecruiting
StartedApril 15, 2024
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedJune 3, 2026
Trial IDNCT05830942 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are older adults aged 65 and above with mild to moderate cognitive decline who can walk independently.

Probably not a fit

Patients with major cognitive disorders or those on medications affecting neuroplasticity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of combining cognitively engaging walking exercises with non-invasive electrical brain stimulation on cognitive and mobility functions in older adults. Participants will engage in complex walking tasks while receiving either active or sham transcranial direct current stimulation (tDCS) over a period of six weeks. The primary outcomes will assess improvements in executive function and walking abilities through standardized assessments. The trial aims to enroll up to 120 older adults with mild to moderate cognitive decline, conducted at two sites in Florida.

Why it matters

Potential benefit: If successful, this approach could enhance cognitive and mobility functions in older adults, potentially improving their quality of life.

How similar studies have gone: Other studies have shown promise in using tDCS for cognitive enhancement, but this specific combination of interventions is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 65+
* Objective executive function decline, based on standardized cognitive assessments.
* Subjective cognitive decline, based on the question: "During the past 12 months, have you experienced confusion or memory loss that is happening more often or getting worse?"
* Ability to walking independently for 6 minutes (use of cane permitted)

Exclusion Criteria:

* Major cognitive disorder that interferes with independence
* Percentile score less than 10th percentile on standardized cognitive assessments
* Medications that are thought to influence tDCS neuroplasticity.
* Contraindications to tDCS or MRI.

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting
  • Brooks Rehabilitation
    Jacksonville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: David J Clark, ScD — University of Florida
  • Study coordinator: David J Clark, ScD
  • Email: davidclark@ufl.edu
  • Phone: 352-376-1611

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.